Expert Opinion on Investigational Drugs, Volume 32, Issue 3 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 32, Issue 3 (2023)

See all volumes and issues
Vol 33, 2024 Volume 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Editorial
Lipid metabolism and the targeting of angiopoietin-like 3: Experimental drugs under development
Georgios Polychronopoulos, Danai-Thomais Kostourou & Konstantinos Tziomalos
Pages: 177-180
Published online: 17 Feb 2023
First Page PreviewforLipid metabolism and the targeting of angiopoietin-like 3: Experimental drugs under development | Full Text | References | PDF (201.9 KB) | EPUB
  • 820 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis
Suky Martinez, Hannah Harris, Thomas Chao, Rachel Luba, Marco Pravetoni, Sandra D Comer & Jermaine D Jones
Pages: 181-185
Published online: 06 Mar 2023
First Page PreviewforThe potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis | Full Text | References | PDF (256.1 KB) | EPUB
  • 1529 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Five years after PACIFIC: update on multimodal treatment efficacy based on real-world reports
Farkhad Manapov, Alexander Nieto, Lukas Käsmann, Julian Taugner, Saskia Kenndoff, Benedikt Flörsch, Julian Guggenberger, Kerstin Hofstetter, Sophie Kröninger, Janina Lehmann, Helene Kravutske, Carolyn Pelikan, Claus Belka & Chukwuka Eze
Pages: 187-200
Published online: 22 Feb 2023
AbstractforFive years after PACIFIC: update on multimodal treatment efficacy based on real-world reports | Full Text | References | PDF (336.4 KB) | EPUB
  • 253 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, Ana Oaknin, David Cibula & Toon Van Gorp
Pages: 201-211
Published online: 07 Mar 2023
AbstractforInvestigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline? | Full Text | References | PDF (398.3 KB) | EPUB
  • 2266 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review
Role of bromodomain and extraterminal (BET) proteins in prostate cancer
Adel Mandl, Mark C. Markowski, Michael A. Carducci & Emmanuel S. Antonarakis
Pages: 213-228
Published online: 09 Mar 2023
AbstractforRole of bromodomain and extraterminal (BET) proteins in prostate cancer | Full Text | References | PDF (3.7 MB) | EPUB
  • 290 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Investigational systemic drugs for moderate to severe plaque psoriasis: What’s new?
Laura Calabrese, Dalma Malvaso, Flaminia Antonelli, Maria Mannino, Ketty Peris & Andrea Chiricozzi
Pages: 229-243
Published online: 03 Mar 2023
AbstractforInvestigational systemic drugs for moderate to severe plaque psoriasis: What’s new? | Full Text | References | PDF (1.7 MB) | EPUB
  • 265 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities
Le Yu Naing, Matthew Heckroth, Prateek Mathur & Thomas L Abell
Pages: 245-262
Published online: 28 Mar 2023
AbstractforGastroparesis syndromes: emerging drug targets and potential therapeutic opportunities | Full Text | References | PDF (3.3 MB) | EPUB
  • 206 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects
Yanli Wang, Jinling Xue, Zhengjie Su, Yingzi Cui, Guangwen Liu, Wei Yang, Zhengzhi Liu, Jiahui Chen, Qing Ren, Shuang Yu, Yang Cheng, Yannan Zhou, Wanhua Wang, Xuesong Chen, Dongmei Qu, Qiaohuan Deng, Yicheng Zhao & Haimiao Yang
Pages: 263-270
Published online: 18 Feb 2023
AbstractforPharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects | Full Text | References | PDF (304.5 KB) | EPUB | Supplemental
  • 230 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?
Sophie E. Field et al.
Review Article | Published online: 17 May 2024
Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status
Fernanda Karoline Vieira da Silva Torchelsen et al.
Review Article | Published online: 14 May 2024
Emerging therapies for overactive bladder: preclinical, phase I and phase II studies
Samantha Gibson et al.
Review Article | Published online: 9 May 2024
Frontotemporal dementia: from genetics to therapeutic approaches
Francesca R. Buccellato et al.
Review Article | Published online: 9 May 2024
Open Access
View all latest articles